Harding, Pamela <br/><br/>
COX-2 inhibition potentiates the antiproteinuric effect of enalapril in uninephrectomized SHR.  [electronic resource] 

 -  Prostaglandins, leukotrienes, and essential fatty acids  Jan 2003 
 - 17-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0952-3278 
<br/><br/><label>Standard No.: </label>10.1016/s0952-3278(02)00231-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Blood Pressure<br/>Body Weight<br/>Collagen Type II--metabolism<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Enalapril--pharmacology<br/>Hypertrophy--pathology<br/>Isoenzymes--antagonists & inhibitors<br/>Kidney Diseases--enzymology<br/>Male<br/>Nephrectomy<br/>Nitrobenzenes--pharmacology<br/>Organ Size<br/>Prostaglandin-Endoperoxide Synthases--physiology<br/>Prostaglandins--urine<br/>Proteinuria--enzymology<br/>Rats<br/>Rats, Inbred SHR<br/>Rats, Inbred WKY<br/>Sulfonamides--pharmacology